PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Modeling Systems

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BMSystems Filed A Patent in CNS Covering New Therapeutic Strategies for Psychiatric Disorders - BMSystems filed on Septembers 10, with CEA life Sciences, a patent application covering new therapeutic strategies and a preclinical evaluation platform in the field of psychiatric disorders
BMSystems Filed A Patent in CNS Covering New Therapeutic Strategies for Psychiatric Disorders

 

NewswireToday - /newswire/ - Paris, Ile-de-France, France, 2008/09/27 - BMSystems filed on Septembers 10, with CEA life Sciences, a patent application covering new therapeutic strategies and a preclinical evaluation platform in the field of psychiatric disorders.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The utilization of CADI*™ (biological modeling approach and technologies) leads to a new industrial success in CNS diseases. BMSystems filed on Septembers 10, 2008, with CEA life Sciences**, a patent application covering new therapeutic strategies and a preclinical evaluation platform in the field of psychiatric disorders.

This shared patent illustrates the unique efficacy of BMSystems’ proprietary CADI™ technologies, the excellence of the respective research teams and the successful application of the collaborative CADI™ four steps validation process.

After the successful launch and financing, in 2006, of its spin-off Pherecydes-Pharma (infectious diseases, 2 patents), Bio-Modeling Systems confirms the power of its business strategy to create immediate value through collaborations with partners.

We are also very proud of our strong scientific recognition in neurological sciences, materialised through the publication of the collaborative scientific reference textbook: Biomarkers for Psychiatric Disorders (Ref. ISBN: 978-0-387-79250-7, November 2008). Dr. François Iris is the author of the “Integrative Biology” chapter in this book. The editor, Christoph W. Turck, is head of the Proteomics and Biomarkers branch at the Max Planck Institute of Psychiatry

We warmly invite you to visit our new website and download our new presentation with three case studies that illustrate through facts the capability of our CADI™ platform to really deliver.

*CADI™: Computer Assisted Deductive Integration; The predictive integrative biology approach invented & developed by BMSystems.

** CEA life Sciences: Atomic Energy Council Life Sciences unit, one of the major life sciences institutions in France.

BMSystems is participating to EuroBiO2009 partnering. Do not hesitate to meet us during this event.

About BMSYSTEMS
BMSYSTEMS (bmsystems.net) is an independent research-based biotech company that creates CADI™ models of biological systems (pathologies, embryology, bacterial metabolism, etc.) to generate businesses with immediate applications.

BMSystems’ mission
We propose to our partners and clients to help them run their life sciences R&D programs better, faster, cheaper and safer by applying together our CADI™ methodologies and tools, the first fully operational systems biology approach, repeatedly proven to generate results and more profitable business.

BMSystems’ activities: two complementary synergic activities:

• BMSystems creates new knowledge from raw information and,
• BMSystems generates real business from this new knowledge.

BMSystems’ research approaches: competitive disruptive innovations:

• BMSystems invented CADI™ (Computer Assisted Deductive Integration) in 2002, the first integrative approach based on “negative selection” concept that generated the world first, and only to date, validated and published in-silico model on a complex human disease.

• BMSystems re-invented and made highly productive the synergic collaboration between experimental biology and integrative biology to validate and improve its CADI™ models.

• Because life is a non-linear integrative process, our company decided, in 2001, to switch from “leading Cartesian concepts” still under development by competitors, to CADI™, the most effective synergic methodologies and tools linking organic non-linear integration (Brain intelligence) and in-silico data processing power (collecting, structuring and manipulating data).

• BMSystems competitive advantages are proven every day through publications and value creations.

BMSystems’ business model: an original framework already implemented:

• BMSystems does not sell its technologies nor access to its technologies. The company adopted the “black box” strategy to protect its unique competitive advantages, and concentrates all its resources to develop its CADI™ approach.

• BMSystems is a research-based company that creates CADI™ models to generate businesses with immediate applications.

• BMSystems, through its “Intel inside” strategy, co-develops* the business potential of its proprietary CADI™ models with selected partners in the relevant domains of application to generate the maximum value form its R&D investments.

• BMSystems, thanks to its collaborative strategy, can address with limited marketing costs, all the markets (biomedical, chemistry, energy, environment, etc…) where its CADI™ models generate strong competitive advantages for its partners.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Modeling Systems

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BMSystems Filed A Patent in CNS Covering New Therapeutic Strategies for Psychiatric Disorders

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Manuel Gea - BMSystems.net 
+33(0)6 83 06 12 72 manuel.gea[.]bmsystems.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Modeling Systems securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Modeling Systems / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)